Safer and faster procedures may improve recovery times, enhance the patient experience and increase access to treatment.

Atrial fibrillation is a common arrhythmia that affects an estimated 30 million people worldwide. New research shows that catheter ablation, a common cardiovascular procedure, appears no more ...

Biosense Webster’s Thermocool SmartTouch SF dual-energy catheter enables the use of both radio-frequency (RF) and pulse-field (PF) techniques in catheter ablation procedures. The SmartfIRE pivotal, ...

IRVINE, Calif., Nov. 2, 2023 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced new findings from the Q-FFICIENCY ...

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased ...

Millions of people around the world are diagnosed with heart failure and atrial fibrillation every year. In the weakened state, the heart is unable to pump enough oxygenated blood throughout the body.

Medical device suppliers that produce parts and components for pulsed field ablation (PFA) catheters designed to treat atrial fibrillation (AFib) are optimistic about growth since Medtronic’s ...

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of stroke enough that some patients can discontinue blood thinners, according to a ...

An international consensus statement on how to treat atrial fibrillation with catheter or surgical ablation has been published in EP Europace and presented at EHRA 2024. Lead author Dr. Stylianos ...

The FDA approved the first pulsed field ablation (PFA) catheter, the PulseSelect PFA system, for the treatment of paroxysmal and persistent atrial fibrillation (Afib), Medtronic announced on Wednesday ...

Catheter ablation was favored for rhythm control in atrial fibrillation (Afib or AF) when considering its psychological benefits over medical therapy alone, the REMEDIAL randomized trial showed.